Amarin signs agreement with Neopharm to market VAZKEPA in Israel
The agreement for VAZKEPA capsules comes after approval from Israel’s Ministry of Health (MOH) Pharmaceuticals Division. The approval of these capsules has been granted for reducing cardiovascular events